John M. Engel

John Engel is founder and managing partner of EngelNovitt PLLC, an internationally-recognized boutique law firm specializing in food and drug, public health, and administrative law, and health information technology and science policy, and legislation impacting the life sciences, health care, and biopharmaceutical industries.

A longtime friend of Virginia Tech, his relationship with the university dates back to work in the 1990s in connection with a pioneering collaborative research-and-development agreement at the university that led to the development of a semisynthetic process to produce a lifesaving drug that fights cancer. 

Engel serves on the College of Science Dean’s Roundtable Advisory Board and is a member of the university’s Ut Prosim Society.